How should cabergoline be used correctly in patients with pituitary microadenoma?

When taking cabergoline in patients with pituitary microadenomas, the patient should undergo a thorough medical evaluation, particularly regarding pituitary function and the size and nature of the adenoma, before starting cabergoline. It is recommended to perform sella turcica X-ray radiography, CT scan or MRI to accurately understand the status of the adenoma and rule out other possible complications.

The starting dose of cabergoline is usually 0.25～0.5mg, and the maintenance dose is adjusted according to the patient's response and prolactin level, generally between 0.25～3mg per week. Dosage adjustments should be made gradually and under close supervision by a physician to ensure optimal therapeutic effects while avoiding unnecessary side effects.

Cabergoline can be taken orally and should be taken with or after food to reduce gastrointestinal adverse effects. Patients should follow a fixed dosing schedule to ensure stable levels of the drug in the body.

During the use of cabergoline, patients may experience some side effects, such as nausea, headache, constipation, etc. These symptoms are usually mild and may gradually decrease with treatment.

However, long-term use of cabergoline may increase the risk of valvular heart disease. Therefore, patients should have regular heart function tests, especially echocardiography, to monitor for any potential heart problems.

Patients who are trying to conceive or are pregnant should be particularly cautious and consult their doctor before using cabergoline. It is generally recommended to stop using cabergoline at least one month before you intend to conceive.

If the patient develops liver function impairment during medication, the dose should be reduced or the medication should be discontinued, and corresponding treatment should be carried out under the guidance of a doctor.

During treatment with cabergoline, patients should receive regular follow-up and reexaminations from their doctors to evaluate the treatment effect, adjust the treatment plan, and detect and deal with any potential problems in a timely manner.